Litwa - litewski - SMCA (Valstybinė vaistų kontrolės tarnyba)

chanelle pharmaceuticals manufacturing ltd. (airija) - injekcinis tirpalas - 1 ml tirpalo yra: veikliosios (-iųjų) medžiagos (-ų): ivermektino 10 mg; klorsulono 100 mg. - jaučiams ir pieniniams galvijams (ne laktacijos metu), užsikrėtusiems skrandžio, žarnyno, plaučių, akių nematodais, odos parazitais, sergantiems fasciolioze, gydyti ir profilaktiškai.

Litwa - litewski - SMCA (Valstybinė vaistų kontrolės tarnyba)

mcneil ab - nikotinas - transderminis pleistras - 25 mg/16 h; 10 mg/16 h; 15 mg/16 h - nicotine

Litwa - litewski - SMCA (Valstybinė vaistų kontrolės tarnyba)

glaxosmithkline dungarvan limited - nikotinas - transderminis pleistras - 21 mg/24 val.; 7 mg/24 val.; 14 mg/24 val. - nicotine

Litwa - litewski - SMCA (Valstybinė vaistų kontrolės tarnyba)

richard bittner ag - nikotinas - suslėgtosios pastilės - 1,5 mg; 21 mg/24 val.; 14 mg/24 val.; 7 mg/24 val. - nicotine

Litwa - litewski - SMCA (Valstybinė vaistų kontrolės tarnyba)

sun pharmaceutical industries europe b. v. - lopinaviras/ritonaviras - plėvele dengtos tabletės - 100 mg/25 mg; 200 mg/50 mg - lopinavir and ritonavir

Litwa - litewski - SMCA (Valstybinė vaistų kontrolės tarnyba)

lex ano, uab - melfalanas - milteliai ir tirpiklis injekciniam tirpalui - 50 mg - melphalan

Litwa - litewski - SMCA (Valstybinė vaistų kontrolės tarnyba)

ideal trade links, iĮ - ketorolako trometamolis - plėvele dengtos tabletės - 10 mg - ketorolac

Unia Europejska - litewski - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - sitagliptin fumarate - cukrinis diabetas, 2 tipas - narkotikai, vartojami diabetu - for adult patients with type 2 diabetes mellitus, sitagliptin sun is indicated to improve glycaemic control:as monotherapy:- in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance. as dual oral therapy in combination with:- metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control. - a sulphonylurea when diet and exercise plus maximal tolerated dose of a sulphonylurea alone do not provide adequate glycaemic control and when metformin is inappropriate due to contraindications or intolerance. - a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. a thiazolidinedione) when use of a pparγ agonist is appropriate and when diet and exercise plus the pparγ agonist alone do not provide adequate glycaemic control. as triple oral therapy in combination with:- a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. - a pparγ agonist and metformin when use of a pparγ agonist is appropriate and when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. sitagliptin sun is also indicated as add-on to insulin (with or without metformin) when diet and exercise plus stable dose of insulin do not provide adequate glycaemic control.

Unia Europejska - litewski - EMA (European Medicines Agency)

sun pharmaceutical industries (europe) b.v. - ertapenemo natrio druska - bakterinė infekcija - ertapenem - treatmentertapenem sun is indicated in paediatric patients (3 months to 17 years of age) and in adults for the treatment of the following infections when caused by bacteria known or very likely to be susceptible to ertapenem and when parenteral therapy is required (see sections 4. 4 ir 5. 1):- intra-abdominal infections- community acquired pneumonia- acute gynaecological infections- diabetic foot infections of the skin and soft tissue (see section 4. 4)preventionertapenem sun is indicated in adults for the prophylaxis of surgical site infection following elective colorectal surgery (see section 4. reikėtų atsižvelgti į oficialius nurodymus, kaip tinkamai naudoti antibakterinių veiksnių.

Unia Europejska - litewski - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - teriparatide - osteoporosis; osteoporosis, postmenopausal - kalcio homeostazė - teriparatide sun is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.